Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Chinese Medicine
  4. Vol 7, Issue 3, 2025

Pathogenesis and Treatment of Coronary Heart Disease Based on Metabolic Abnormalities from the Perspective of "Damp-Turbidity and Phlegm-Rheum Type of Diseases"

Download as PDF

DOI: 10.23977/medcm.2025.070309 | Downloads: 3 | Views: 147

Author(s)

Zhang Zhengwei 1, Jia Fuyun 1, Ma Yinan 1, Cui Hanwen 1, Zhao Xinwei 1, Xu Qiang 2

Affiliation(s)

1 Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China
2 The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300150, China

Corresponding Author

Xu Qiang

ABSTRACT

This paper explores the pathogenesis and treatment of coronary heart disease (CHD) from the perspective of metabolic abnormalities, guided by the Traditional Chinese Medicine (TCM) theory of "Damp-turbidity and Phlegm-rheum Type of Diseases." It examines the intrinsic connection between metabolic abnormalities and these syndromes, as well as their close link to the development of CHD. Metabolic disorders are the physiological foundation for the occurrence and progression of CHD and represent the microscopic essence of pathological products such as dampness and phlegm. Therefore, addressing metabolic imbalances is essential in the treatment process. At the onset of the disease, therapies should focus on eliminating dampness, invigorating the spleen, regulating qi, and promoting blood circulation to improve sugar and lipid metabolism. When dampness lingers for a long time, treatments should aim to transform dampness, clear turbidity, regulate qi, and activate blood circulation to protect vascular endothelial damage. As the disease progresses, treatment should aim at resolving phlegm, removing blood stasis and coordinating the internal organs to restore the damaged heart function. In severe cases, treatment should focus on warming Yang, transforming water and tonifying qi to prevent the occurrence of complications such as heart failure.

KEYWORDS

Coronary Heart Disease; Metabolic Disorder; Zhang Boli; Damp-turbidity and Phlegm-rheum Type of Diseases

CITE THIS PAPER

Zhang Zhengwei, Jia Fuyun, Ma Yinan, Cui Hanwen, Zhao Xinwei, Xu Qiang, Pathogenesis and Treatment of Coronary Heart Disease Based on Metabolic Abnormalities from the Perspective of "Damp-Turbidity and Phlegm-Rheum Type of Diseases". MEDS Chinese Medicine (2025) Vol. 7: 58-66. DOI: http://dx.doi.org/10.23977/medcm.2025.070309.

REFERENCES

[1] Benjamin, E.J., Virani, S.S., Callaway, C.W., Chamberlain, A.M., Chang, A.R., Cheng, S., Chiuve, S.E., Cushman, M., Delling, F.N., and Deo, R. (2018). Heart Disease and Stroke Statistics-2018 Update: A Report from the American Heart Association. Circulation, 137(12), e67-e492.
[2] Gu, D.F., Weng, J.P., and Lu, X.F. (2020). Chinese Guideline on Healthy Lifestyle to Prevent Cardiometabolic Diseases. Chinese Circulation Journal, 35(3), 209-230.
[3] Prasher, D., Greenway, S.C., and Singh, R.B. (2020). The Impact of Epigenetics on Cardiovascular Disease. Biochemistry and Cell Biology, 98(1), 12-22.
[4] Yang, X.Y., Li, K., Song, J.Q., et al. (2025). The association between triglyceride-glucose index and the recurrence of myocardial infarction in young patients with previous coronary heart disease. Scientific Reports, 15(1), 31490.
[5] Altura, B.M., Altura, B.T. (1984). Magnesium, electrolyte transport and coronary vascular tone. Drugs, 28(Suppl 1), 120-142.
[6] Bi, Y.F., Mao, J.Y., Wang, X.L., Zhao, Z.Q., Li, B., and Hou, Y.Z. (2015). Clinical Advantages of Traditional Chinese Medicine in Preventing and Treating Coronary Heart Disease and Related Thoughts on Efficacy Evaluation. Journal of Traditional Chinese Medicine, 56(5), 437-440.
[7] Li, X., Jin, X.Y., Lyu, L., Zhao, M.Y., Cui, Y.W., Yang, F.W., Jiang, F., and Zhang, L. (2022). ZHANG Boli's Academic Concept of "Similar Diseases and Syndromes of Damp-Turbidity-Phlegm-Rheum and the Treatment". Journal of Traditional Chinese Medicine, 63(17), 1620-1624.
[8] Khan, A.W. and Jandeleit-Dahm, K.A.M. (2025). Atherosclerosis in Diabetes Mellitus: Novel Mechanisms and Mechanism-Based Therapeutic Approaches. Nature Reviews Cardiology, 22, 482-496.
[9] Yubero-Serrano, E.M. and Pérez-Martínez, P. (2020). Advanced Glycation End Products and Their Involvement in Cardiovascular Disease. Angiology, 71(8), 698-700.
[10] Hu, S.G., Cheng, Z.W., Li, M., Gao, S.Y., Gao, D.S., and Kang, P.F. (2024). Correlation Between Insulin Resistance and Coronary Collateral Circulation in Patients with Chronic Total Coronary Occlusion. Journal of Southern Medical University, 44(4), 780-786.
[11] Stern, M.P. (1995). Diabetes and Cardiovascular Disease: The "Common Soil" Hypothesis. Diabetes, 44(4), 369-374.
[12] Gengatharan, J.M., Handzlik, M.K., Chih, Z.Y., Ruchhoeft, M.L., Secrest, P., Ashley, E.L., Green, C.R., Wallace, M., Gordts, P.L.S.M., and Metallo, C.M. (2025). Altered Sphingolipid Biosynthetic Flux and Lipoprotein Trafficking Contribute to Trans-Fat-Induced Atherosclerosis. Cell Metabolism, 37(1), 274-290.
[13] Itabe, H. (2009). Oxidative Modification of LDL: Its Pathological Role in Atherosclerosis. Clinical Reviews in Allergy & Immunology, 37, 4-11.
[14] Ai, D., Chen, C., Han, S., Ganda, A., Murphy, A.J., Haeusler, R., Thorp, E., Accili, D., Horton, J.D., and Tall, A.R. (2012). Regulation of Hepatic LDL Receptors by mTORC1 and PCSK9 in Mice. Journal of Clinical Investigation, 122(4), 1262-1270.
[15] Duffy, D. and Rader, D.J. (2009). Update on Strategies to Increase HDL Quantity and Function. Nature Reviews Cardiology, 6(7), 455-463.
[16] Mao, C.H., Long, D., Ma, W.Q., Shen, J.P., Dong, Q.M., and Wang, X.D. (2022). Experience of DONG Qimei in Treating Dampness Syndrome of Heart Diseases by "Three Kernels Decoction" with Compatibility of Trio Herbs. Guiding Journal of Traditional Chinese Medicine and Pharmacology, 28(8), 137-139, 147.
[17] Wang, X. and Zhang, M.X. (2024). Analysis of the Application of "Acrid-Sweet Herbs Transforming Yang" Method in Coronary Heart Disease Based on Shanghan and Wenbing Theory. Chinese Journal of Basic Medicine in Traditional Chinese Medicine, 30(8), 1407-1410.
[18] Xiang, H., Cui, Y.Y., Zhu, Y.T., Zhao, L., Guan, X., Bai, C.C., and Shang, D. (2023). Discussion on the Treatment of Hypertriglyceridemic Pancreatitis Based on Lipid Turbidity Theory. Journal of Traditional Chinese Medicine, 64(15), 1612-1615.
[19] Hou, W.Y., Ding, L.J., Chen, R., Gu, R.Y., and Zhang, Y.Y. (2024). Professor GU Renyue's Experience in Treatment of Heart Failure with Preserved Ejection Fraction Based on Syndrome Differentiation. World Journal of Integrated Traditional and Western Medicine, 19(7), 1339-1342.
[20] Zhong, D.S., Yao, K.W., Li, N., Lin, J.G., Duan, J.L., Wang, Q.Q., Li, C., Sun, X.N., Zhang, X.X., and Tan, M. (2024). Application Progress of Metabonomics in Diagnosis and Treatment of Coronary Heart Disease by Traditional Chinese Medicine. China Journal of Traditional Chinese Medicine and Pharmacy, 39(7), 3597-3602.
[21] Han, X.Y., Wang, J.L., Lyu, J.L., Zhang, S., Pan, X., Han, Y., Zhang, T., and Chen, Y.G. (2024). Application of Metabolomics in Prognostic Research of Cardiovascular Diseases. China Preventive Medicine, 25(2), 158-165.
[22] Yang, B.B., Guo, K., and Wang, H.J. (2023). Interpretation of Expert Consensus on the Prevention and Treatment of Infantile Diarrhea by Integrating Traditional Chinese and Western Medicine. World Chinese Medicine, 18(16), 2261-2264+2272.
[23] Mo, C., Shi, W., Wang, X.Q., Xiang, C.Y., Hu, W., and Zhao, J. (2018). Research and Application of Treatment-Related Effects of Hirudo on Blood-Stasis Syndrome of Kidney Disease. Chinese Archives of Traditional Chinese Medicine, 36(1), 130-132.
[24] Zhang, P., Li, Y.Y., Shao, Y.F., and Gao, B.Z. (2021). Comparative Study of Serum Metabolomics Between Phlegm Syndrome and Dampness Syndrome of Metabolic Syndrome. China Journal of Traditional Chinese Medicine and Pharmacy, 36(3), 1627-1632.
[25] Huang, J., Yao, X.Q., Xiong, Y.H., Yang, M., Su, M., and Zhang, X.Z. (2024). Correlation of Coronary Angiography and Blood Biochemical Indexes Among Different Chinese Medicine Syndromes of Coronary Atherosclerotic Heart Disease. Chinese Journal of Integrated Traditional and Western Medicine, 44(2), 149-155.
[26] Ren, S., Liu, Y.T., and Zhang, J. (2021). Discussion on The Modern Medical Nature of Phlegm Dampness. Chinese Journal of Basic Medicine in Traditional Chinese Medicine, 27(9), 1515-1518.
[27] Wei, J.P., Yang, Y., Zhang, X.M., and Xu, S.J. (2024). Discussion on the Prevention and Treatment of Dementia from Body Fluid Metabolism. World Science and Technology-Modernization of Traditional Chinese Medicine, 26(4), 895-901.
[28] Sun, M., Wang, Y.Y., Meng, X.Y., Xu, F., and Kuang, H.Y. (2022). Exploration on the Scientific Connotation of TCM Pathogenesis of PCOS Based on "Kidney Deficiency, Phlegm-Dampness and Blood Stasis". Lishizhen Medicine and Materia Medica Research, 33(6), 1412-1415.
[29] Ma, H.Y., Li, B., Liu, L., Gui, H., Wang, X.Y., Huang, X.X., Zhao, L.L., Zhang, Y.T., and Guo, H.L. (2024). Study on the Correlation Between Ischemic Stroke of Phlegm and Blood Stasis Blocking Collaterals and Clinical Laboratory Index. China Medicine, 19(8), 1228-1232.
[30] Li, L.L., Hu, X., and Liu, H.X. (2022). Clinical Study of Cangzhu Mahuang Decoction on the Improvement of Blood Lipid Levels and Traditional Chinese Medicine Symptoms in Patients with Phlegm Block Syndrome of Dyslipidemia. China Medicine, 17(10), 1550-1554.
[31] An, X.D., Zhang, N., Duan, L.Y., Yu, X., Zhou, Z.L., Lian, F.M., Cui, N.Q., and Tong, X.L. (2024). Rational Dose of Dachengqi Decoction in the Treatment of Primary and Non-Primary Acute Intestinal Obstruction: A Randomize-Controlled, Double-Blinded, Multicentered Clinical Trial. Journal of Traditional Chinese Medicine, 65(21), 2217-2224.
[32] Lu, S.H., Zhao, R.H., Yao, C., Chen, X.S., Han, M.N., and Yu, J. (2016). Research Progress on Chemistry and Pharmacology of Amomi Fructus. Pharmacology and Clinics of Chinese Materia Medica, 32(1), 227-230.
[33] Guo, J., Jin, Z.R., Guo, F., Li, B., and Zhang, X. (2022). Effect and Mechanism of Saussurea lappa C.B.Clarke Ethanol Extract on High Glucose-Induced Vascular Endothelial Cell Injury. Chinese Journal of New Drugs and Clinical Remedies, 41(10), 629-634.
[34] Chen, Y.X., Tang, L.Q., Liang, J.R., Zhang, S.B., Chen, B.F., and Chen, J.F. (2020). Nuciferine Promotes Proliferation of Human Aortic Endothelial Cell by Up-Regulating SDF-1/CXCR4 Signaling Pathway. Chinese Journal of Arteriosclerosis, 28(11), 981-985.
[35] Yan, L., Ou, Z.M., Wang, Y.J., Zhang, Y., Cheng, Y., Wang, Z.C., Liu, D.W., Wang, J.Y., Ma, Z.S., and Tong, Y. (2023). Comparative Analysis of Serum Pharmacochemistry of Alismatis Rhizoma Before and After Salt Processing Based on UPLC-Q-TOF-MS. Chinese Journal of Experimental Traditional Medical Formulae, 29(23), 122-130.
[36] Song, P., Na, N., and Wang, Y. (2023). Effects of Saikosaponin D on Insulin Resistance and FoxO1/PGC-1α Pathway in Type 2 Diabetic Rats. Chinese Journal of Immunology, 39(7), 1425-1430.
[37] Yu, Z.Q., Zhang, L.Q., Cai, Y.H., Wu, Y.F., Yuan, X., He, F.Y., and Zhou, J. (2024). Research Progress on "Homologous Different Effects" of Aurantii Fructus Immaturus and Aurantii Fructus. China Journal of Chinese Materia Medica, 49(19), 5135-5146.
[38] Li, W.X., Tang, Y.P., Shi, X.Q., Guo, J.M., Liu, P., and Duan, J.A. (2013). Herb Pair Research (IV): Compatibility Effects of Herb Pairs. China Journal of Chinese Materia Medica, 38(24), 4203-4207.
[39] Wang, W.Y., Zhu, Z.J., Li, H.F., and Xu, S.M. (2024). Research Progress on Chemical Constituents and Pharmacological Effects of Banxia (Pinelliae Rhizoma) and Prediction Analysis of Quality Markers. Journal of Liaoning University of Traditional Chinese Medicine, 26(3), 203-215.
[40] Gu, Y.Y., Zhong, Z.H., Wang, W.Y., Liu, T.T., Zhang, X., Gong, Y., and Cao, J.L. (2022). Mechanism of Trichosanthes Peel Injection in the Treatment of Coronary Heart Disease and Angina Pectoris: A Network Pharmacology-Based Study. Clinical Medication Journal, 20(2), 47-54.
[41] Li, Z.H., Bi, J.N., and Wu, X.A. (2024). CiteSpace Scientific Literature Visual Analysis of Research Hotspots of Sparganii Rhizoma. Chinese Journal of New Drugs and Clinical Remedies, 43(4), 311-317.
[42] Zhu, C.Y., Hu, J., Liu, L.C., Qu, P.R., and Wang, J. (2024). Application of Insect Medicines in Treatment of Coronary Microvascular Dysfunction Based on Comorbidity Theory of "Blood-Vessel-Cardiac Collaterals". Chinese Journal of Experimental Traditional Medical Formulae, 30(1), 176-185.
[43] Cui, R.Y. and Xu, H.Y. (2019). Study on Quality Markers of Ginseng Acting on Heart Failure Based on TCMIP V2.0. Chinese Traditional and Herbal Drugs, 50(19), 4628-4633.
[44] Gao, Z.H. and Xie, X. (2025). Mechanism of Action and Research Progress of the Chinese Medicine Huangqi (Astragali Radix) Against Diabetic Cardiomyopathy. Journal of Liaoning University of Traditional Chinese Medicine, 27(3), 43-47.
[45] Wang, M. and Zhang, S.C. (2024). Experience of Zhang Sichao in Treating Chronic Cough. Acta Chinese Medicine, 39(4), 787-792.
[46] Fu, Z.H., Shi, L., Mao, T.Y., Shi, R., Chen, X.W., Wei, S.B., and Li, J.X. (2024). Professor LI Junxiang's Clinical Thinking in the Treatment of Ulcerative Colitis Using Classic Prescriptions. Chinese Journal of Integrated Traditional and Western Medicine on Digestion, 32(10), 849-854.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 8560
Visits: 486294

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.